CTI BioPharma
Location | 3101 Western Space | 22,000 SF Project Outcome | Renewal / Disposition
CTI BioPharma focuses on the acquisition, development and commercialization of therapies for blood-related cancers that offer unique benefits to patients and is listed on the NASDAQ under the symbol CTIC. In 2017 Flinn Ferguson Cresa was engaged by CTI to sublease two of their 3 floors of office space at 3101 Western Ave. Flinn Ferguson successfully subleased both floors and has subsequently helped CTI with lease renewals.
